期刊文献+

ABSIS评分在寻常型天疱疮患者中的应用 被引量:5

Autoimmune Bullous Skin Disorder Intensity Score(ABSIS) in the treatment of patients with pemphigus vulgaris
原文传递
导出
摘要 目的 探讨自身免疫性大疱性皮肤病严重程度评分(ABSIS评分)在寻常型天疱疮治疗中的应用价值。方法 对本科的16例寻常型天疱疮入院时、激素减量时及出院时应用ABSIS评分法进行皮肤及黏膜严重程度评分,并同时记录患者的抗天疱疮抗体滴度。结果 入院时、糖皮质激素减量时及出院时ABSIS皮肤评分中位数分别为55,36及15.5,平均52.8,34.3和15.4,ABSIS黏膜评分中位数分别为3/16,2/8.5及0/0,平均3.3/15.8,2.1/8.3和0.6/1.1。抗天疱疮抗体滴度中位数分别为1:160,1:80及1:40,平均1:387.5,1:141.3及1:55。结论 ABSIS评分可从患者的皮损面积及质量、受累口腔黏膜数量及质量方面全面评价天疱疮患者的病情,比监测抗天疱疮抗体滴度能更灵敏的反应病情变化情况,可用于指导寻常型天疱疮患者的治疗及护理。 Objective To investigate the usefulness of Autoimmune BuUous Skin Disorder Intensity Score (ABSIS) in the treatment of patients with pemphigus vulgaris in China. Methods Sixteen patients who were diagnosed as pemphigus vulgaris were evaluated by ABSIS when admitted, reduction of steroid and discharged. Record serum autoantibody titres tested by indirect immunofluoreseence. Results The median ABSIS values for skin in the patients with pemphigus vulgaris when they were admitted, reduction of steroid and discharged were 55. 36, 15.5, and the average value were 52.8, 34.3, 15.4, respectively. The median ABSIS score for mucosal lesions were 3/16, 2/8.5,0/0, and the average value were 3.3/15.8, 2.1/8.3, 0.6/1.1, re- spectively. The median serum autoantibody titres were 1 : 160, 1 : 80, 1 : 40, and the average value were 1 : 387.5, 1 : 141.3, 1 : 55, respectively. Conclusion ABSIS consists of a quality and quantity based score for cutaneous lesions and oral mucosal involvement can monitor the status of patients with pemphigus. ABSIS score can truly reflected clinical disease activity while autoantibody titers did not. So ABSIS score can be used as a guidance in the treatment and nursing care of patients with pemphigus vulgaris.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2012年第12期1128-1130,1135,共4页 The Chinese Journal of Dermatovenereology
关键词 天疱疮 ABSIS 护理 评分 pemphigus ABSIS nursing care score
  • 相关文献

参考文献6

二级参考文献26

  • 1Groves RW.Pemphigus:a brief reviw[J].Clin Med,2009,9(4):371-375.
  • 2Stanley JR.Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid bullous diseases due to defective epidermal cell adhesion[J].Adv Immunol,1993,53:291-325.
  • 3Ishii K,Amagai M,Hall RP,et al.Characterization of autoantibodies in pemphigus using antigen-specific ELISAs with baculovirus expressed recombinant desmogleins[J].J Immunol,1997,159(4):2010-2017.
  • 4Amagai M,Komai A,Hashimoto T,et al.Usefulness of enzymelinked immunosorhent assay(ELISA)using recombinant desmogleins 1 and3 for serodiagnosis ef pemphigus[J].Br J Dermatol,1999,140(2):351-357.
  • 5Abasq C,Mouquet H,Gilbert D,et al.ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus[J].Arch Dermatol,2009,45(5):529-535.
  • 6Cheng SW,Kobayashi M,Kineshita-Kuroda K,et al.Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3[J].Br J Dermatol,2002,147(2):261-265.
  • 7Pfütze M,Niedermeier A,Hertl M,et al.Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score(ABSIS)in pemphigus[J].Eur J Dermatol,2007,17(1):4-11.
  • 8Aoyama Y,Tsujimura Y,Funabashi M,et al.An experience for ELISA for desmoglein 1,suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus[J].Eur J Dermatol,2000,10(1):18-21.
  • 9Amagai M,Klaus-Kovtun V,Stanley JR.Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris,a disease of cell adhesion[J].Cell,1991,67(5):869 -877.
  • 10Eyre RW,Stanley JR.Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients[J].J Exp Med,1987,165(6):1719-1724.

共引文献26

同被引文献68

  • 1王晓琴,孙艳莉.氦-氖激光治疗皮肤溃疡临床疗效观察[J].临床皮肤科杂志,2005,34(8):503-503. 被引量:15
  • 2马月眉,马月耳,栗玉珍,杨士华,姚军英,马烈,于淞.天疱疮129例临床分析[J].中国皮肤性病学杂志,2005,19(12):731-732. 被引量:7
  • 3彭秀琼.氦-氖激光治疗婴儿阴囊溃疡1例[J].中华物理医学与康复杂志,2006,28(2):94-94. 被引量:2
  • 4Zhu X,Pan J ,Yu Z ,et al. Epidemiol'ogy of pemphigus vul- garis in the Northeast China: A 10-year retrospective study [J]. J Dermato1,2014,41 ( 1 ) :70-75.
  • 5Levy-Sitbon C ,Reguiai Z,Durlach A,et al. Transition from pemphigus vulgaris to pemphigus foliaceus :A case report [J]. Ann Dermatol Venereol,2013,140(12):788-792.
  • 6Pohla-Gubo G,Hintner H.Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases[J].Dermatol Clin,2011,29(3):365-372.
  • 7Daneshpazhooh M,Chams-Davatchi C,Khamesipour A,et al.Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris:correlation with phenotype,severity,and disease activity[J].J Eur Acad Dermatol Venereol,2007,21(10):1319-1324.
  • 8Herrero-González JE,Iranzo P,Benítez D,et al.Correlation of immunological profile with phenotype and disease outcome in pemphigus.[J].Acta Derm Venereol,2010,90(4):401-405.
  • 9Weiss D,Ristl R,Griss J,et al.Autoantibody levels and clinical disease severity in patients with pemphigus:comparison of aggregated anti-desmoglein ELISA values and indirect immunofluorescence titres[J].Acta Derm Venereol,2015,95(5):559-564.
  • 10Anand V,Khandpur S,Sharma VK,et al.Utility of desmoglein ELISA in the clinical correlation and disease monitoring of pemphigus vulgaris[J].J Eur Acad Dermatol Venereol,2012,26(11):1377-1383.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部